ENSURE PLUS ADVANCE VANILLA

Ensure® Plus Advance Vanilla flavor 220ml

ENERGY-DENSE HMB DRINK SCIENTIFICALLY DESIGNED TO HELP IMPROVE NUTRITIONAL STATUS AND PROTECT AGAINST MUSCLE LOSS

  • Energy-dense (150kcal/100ml) formulation for patients with extra energy needs
  • HMB (0.55g/100ml) helps protect against muscle protein breakdown1
  • Contains quality protein (Vanilla flavour: 9.10g/100ml)
  • Contains FOS prebiotics (Vanilla flavour: 0.75g/100ml) to help support gut health

 

IMPORTED FROM THE NETHERLANDS

Ingredients

Water, hydrolized corn starch, sucrose, VEGETABLE OIL (canola oil, corn oil), sodium caseinate, milk protein, soy protein isolate, whey protein concentrate, MINERALS (potassium citrate, sodium citrate, calcium phosphate tribasic, magnesium carbonate, potassium chloride, ferrous sulfate, zinc sulfate, manganese sulfate, cupric sulfate, sodium molybdate, potassium iodide, chromium chloride, sodium selenate), fructo-oligosaccharides, Ca-HMB (calcium β-hydroxy-β-methylbutyrate monohydrate), flavoring sweetener (E957), emulsifier (soy lecithin), stabilizer (cellulose), choline chloride, VITAMINS (ascorbic acid, dl-alpha tocopheryl acetate, niacinamide, calcium pantothenate, beta carotene, pyridoxine hydrochloride, thiamin hydrochloride, riboflavin, Vitamin A palmitate, folic acid, phylloquinone, Vitamin D3, biotin, cyanocobalamin), L-carnitine, stabilizer (sodium carboxymethyl cellulose), stabilizer (gellan gum).

Contains milk and soy ingredients.

Nutrition Information

Nutrition Information
UnitPer 100ml
Energykcal150
Fatg4.80
    Saturated fatty acidsg0.60
    Trans fatg0.08
Carbohydratesg17.55
    Sugarsg7.40
    Fibre (FOS*)g0.75
Proteing9.10
Sodiummg190
HMBg0.55
OTHER CHARACTERISTICS
Osmolality mOsm/kgH2O730
kcal/N (Non-protein kcal/N) ratio103:1 (78:1)
Renal Solute Load mOsm/L671
Gluten freeYes
Lactose maximum<0.25g/100ml 

 

RELATED PRODUCTS

RELATED CONTENT

Examining guidelines and new evidence in oncology nutrition

Examining guidelines and new evidence in oncology nutrition

Main Image


resource

Tagname
Article
title
Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/Examining-guidelines-and-new-evidence-in-oncology-nutrition-a-position-paper-on-gaps-and-opportunities-in-multimodal-approaches-to-improve-pati
Abstract

Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes. 

Publish Date:
Oct 2021

The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)

Main Image

resource

Tagname
ARTICLE
title
The Benefits of Beta-Hydroxy-Beta-Methylbutyrate (or HMB)
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/hmb-article
Abstract

The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.

Publish Date:

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

Main Image

resource

Tagname
Article
title
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
Content Reference
/content/an/hcpproconnect/hk/en/home/adult/resources/public/The-Underappreciated-Role-of-Low-Muscle-Mass-in-the-Management-of-Malnutrition
Abstract

This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.

Publish Date:
Jan 2019

Footnotes:

* Fructo-oligosaccharides.

** Calcium β-hydroxy-β-methylbutyrate monohydrate.

References:

  1. Wilson, Gabriel J et al. Nutr Metab 20085;5:1

 

HKG.2025.58198.AND.1

Order ID: #12345
Order Date: 01/05/2024
Product Product Flavour Product Quantity
Loading...

SESSION TIMEOUT

Your session is about to expire in {min} minutes and you will be logged out. Do you wish to stay logged in?
UK-N/A-2400058 (V8) | October 2024

You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.

You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.

UK-N/A-2400058 (V8) | October 2024
bookmarkbookmarkedbookmark-hover
Click here to add this page to your bookmarks.

This page has been added to your bookmark. To access your bookmark list, Click this link.